HCS Pharma

C’est avec un grand plaisir que nous avons participé à l’étape locale du “Big Tour” de BPI France. La rencontre s’est déroulé à Tourcoing. Cette initiative est destinée à mettre en valeur les entrepreneurs et entrepreneuses de la région Hauts-de-france. Notre CEO, Nathalie Maubon, a été interviewé pour présenter les activités d’HCS Pharma, dans la catégorie deeptech.

HCS Pharma possède le label deeptech de BPI France. Au niveau européen nous sommes également labellisé par Hello Tomorrow. Notre technologie BIOMIMESYS® est ainsi reconnue comme une technologie clef pour la souveraineté de notre continent en santé dans les 50 prochaines années. Nous sommes très heureux de participer à ce grand effort de réindustrialisation. La difficulté en France est le recrutement de business developper sachant vendre des technologie de rupture pour la santé. Si vous aimez les challenges en travaillant dans une équipe jeune et dynamique, n’hésitez pas à nous envoyer votre CV à joinus@hcs-pharma.com.

Nous avons le plaisir de vous inviter le mercredi 6 juillet 2022 à 18h30 à la prochaine soirée Biotech Agora dédiée à HCS Pharma, en présentiel à l’Hôtel Bedford, 17 rue de l’Arcade, 75008 Paris.

Inscrivez vous en suivant ce lien

HCS Pharma est une société à fort potentiel et particulièrement innovante dans la médecine régénérative, située dans les Hauts-de-France.

Lors de cette soirée vous pourrez échanger avec les dirigeants et poser toutes vos questions tant sur le plan scientifique, le développement de la société, son financement que sur les modalités techniques et pratiques de ce financement pré IPO qui a lieu actuellement sur la plateforme Wiseed jusqu’au 24 juillet. Après le vif succès de la première tranche, une nouvelle tranche vient d’être ouverte. Nous rappelons que HCS Pharma projette de s’introduire en bourse en 2023 avec 20 M€ déjà sécurisés.

La société HCS Pharma a pour ambition de récréer via sa technologie BIOMIMESYS des organes en conservant leurs propriétés biomécaniques et biophysiques afin de tester des candidats médicaments et à terme permettre la greffe de ces organes artificiels. Cette technologie permettra également d’adresser le secteur alimentaire en produisant de la viande cultivée.

Nous nous réjouissons de vous retrouver nombreux pour répondre à toutes vos questions.

Inscrivez vous en suivant ce lien

We are very please to annonce our selection in the “CO-INNO INTERNATIONAL” program. Jointly organised by BPI France and Hello Tomorrow, the CO-INNO program accelerates and supports the most cutting-edge French startups from the discovery of the Singaporean ecosystem to the establishment of technological partnerships, funding and even their settlement in Singapore.

Singapore is the 8th most innovative economy in the world and 2nd in Asia for innovation, after South Korea according to the 2020 Global Innovation Index (GII). Singapore is an ideal base for a successful development in the ASEAN region. About 1900 French companies have already established themselves here!

This program is organized in 4 steps :

• Phase 1 (May – July) Training session: our executive team will be trained to present our project to Singaporean ecosystem. We will also be introduced to local mentors.
• Phase 2 (Sept. – Oct.) Matchmaking and immersion: First meetings with Singaporean entities (corporate, startups, institutions, etc.) and a full week on the field to visit and network in main innovation hubs. During this phase, we will present our technology at potential partner at SWITCH (Singapore Week of Innovation and Technology).
• Phase 3 (Nov. – Dec.) International expansion: Support for co-innovation partnerships, settlement and application for funding

It’s an amazing opportunity for us to develop our collaborations in Asia in relation with our partners in Japan, Taiwan and South Korea. We want to warmly thanks BPIfrance and Hello Toorrow for such a support.

Congratulations to our colleagues in this adventure : Algama, Technatium, Iumtech and Bfore.ai

Last week we pleased to welcome in Lille the Molecular Devices’ Imaging User Meeting. It was a amazing opportunities to share our imaging practices with attendees. We presented our services and some of our last results in 3D cell biology in relation with our innovative product BIOMIMESYS®. We also talked about our partnership with Junia, and our PhD student, Tarek, presented his amazing work to segment complex 3D pictures with the help of deep learning methods (project VisuAI). If you are interested by this subject, you can read our previous paper about the use of machine learning algorithms.

The visit of our laboratory was a great opportunity for attendees to discover our automation imaging platform “HAPIx” fully integrated by Molecular Devices and, at its heart, our two “Formula 1”, confocal microscopes (ImageXpress® Micro Confocal system).

Thanks to Molecular Devices team we tested the PICO microscope and it was presented during the visit of the laboratory. PICO is a very easy to use microscope and also very easy to install. You don’t believe me? Look at the video below. I installed the microscope in 30 minutes, without any previous knowledge, just guided by an expert from Molecular Devices (thanks Kristyna).

The meeting allowed us to discover great scientific talks, closely related to imaging. As it impossible to summarize all, I asked my colleagues to share the presentation they prefer.

The presentation of Dr. Anna Erikson (Umea University) about the analysis of live worms with ImageXpress MicroConfocal was interesting, because that highlighted that the application scope of image analysis is very broad. Indeed, the analysis of whole animals is very different of 3D in vitro cells analysis that we perform in HCS Pharma, with different challenges, but also with some similarities. That confirmed that images analysis is a powerful tool in research. 

Véronique (Project Leader)

Dr. Maria Clapés Cabrer (SUN Biosciences) presented an innovative technology for organoid culture. This tool is solving especially problems about microscopy automation while allowing the formation of organizing 3D miniature tissues. It is so exciting to see that scientists and the world of biology are all working towards the same goal : developing powerful and innovative human in vitro models for health. Science is so beautiful !

Océane (Project Leader)

I was impressed by Dr. Allan Sauvat (Institut Gustave Roussy, France) and the way he manages to perform high throughput deep learning image analysis using opensource solutions, and how he demystified “Deep Learning” and “Machine Learning” worlds.

Elodie (Project Director)

We can’t wait 2023 for the next User Meeting!